403 related articles for article (PubMed ID: 26915721)
1. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
2. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
[TBL] [Abstract][Full Text] [Related]
3. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
4. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
5. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
Perm J; 2019; 23():. PubMed ID: 31050644
[TBL] [Abstract][Full Text] [Related]
6. Definition of biochemical success following primary whole gland prostate cryoablation.
Levy DA; Ross AE; ElShafei A; Krishnan N; Hatem A; Jones JS
J Urol; 2014 Nov; 192(5):1380-4. PubMed ID: 24813344
[TBL] [Abstract][Full Text] [Related]
7. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
8. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK; MartÃnez CH; Lu C; Ng CK; Pautler SE; Chin JL
Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
[TBL] [Abstract][Full Text] [Related]
9. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
Ng CK; Moussa M; Downey DB; Chin JL
J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.
Siddiqui KM; Billia M; Al-Zahrani A; Williams A; Goodman C; Arifin A; Violette P; Bauman G; Chin JL
J Urol; 2016 Oct; 196(4):1105-11. PubMed ID: 27157372
[TBL] [Abstract][Full Text] [Related]
11. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
12. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
[TBL] [Abstract][Full Text] [Related]
13. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
14. Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence.
Chen PY; Chiang PH; Liu YY; Chuang YC; Cheng YT
Int J Urol; 2018 Jun; 25(6):615-620. PubMed ID: 29756298
[TBL] [Abstract][Full Text] [Related]
15. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
16. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.
Bahn DK; Lee F; Silverman P; Bahn E; Badalament R; Kumar A; Greski J; Rewcastle JC
Clin Prostate Cancer; 2003 Sep; 2(2):111-4. PubMed ID: 15040872
[TBL] [Abstract][Full Text] [Related]
17. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
18. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
[TBL] [Abstract][Full Text] [Related]
19. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.
Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS
World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
